When adjusted for CRP (as a marker of systemic inflammation), both pre-diabetes and diabetes mellitus accounted for an increase of 19% and 37% in plasma NfL levels (adjusted model 2, Table 2). This evidence concerns the gene CRP and diabetes mellitus.